ConductScience.org, home

Paper17455990

Characteristics and impact of drug detailing for gabapentin.

Steinman MA and 4 others. PLoS Med, 2007. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Characteristics and impact of drug detailing for gabapentin. Papers, record 17455990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17455990

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characteristics and impact of drug detailing for gabapentin.
PubMed
Journal
PLoS Med
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steinman MAMichael A
2Harper GMG Michael
3Chren MMMary-Margaret
4Landefeld CSC Seth
5Bero LALisa A

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminesMajor topic
Cyclohexanecarboxylic AcidsMajor topic
Drug IndustryMajor topic
MarketingMajor topic
gamma-Aminobutyric AcidMajor topic
Gabapentin
Humans
Physicians

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K07 AG000912NIA NIH HHSUnited StatesK07AG000912PubMed and NIHNIH RePORTER
K24 AR052667NIAMS NIH HHSUnited StatesK24AR052667PubMed and NIHNIH RePORTER
Z01 AG000912Intramural NIH HHSUnited StatesK07AG000912PubMed and NIHNIH RePORTER
Z01AG000912NIHNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12218627Patterns of preference for information sources in the adoption of new drugs by specialists.Soc Sci Med1990https://conductscience.org/library/papers/2218627PubMed
22398609Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.JAMA1990https://conductscience.org/library/papers/2398609PubMed
38455108The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.J Gen Intern Med1993https://conductscience.org/library/papers/8455108PubMed
48221424Interactions between physicians and the pharmaceutical industry: what does the literature say?CMAJ1993https://conductscience.org/library/papers/8221424PubMed
58204336Attitudes of general practitioners in New Zealand to pharmaceutical representatives.Br J Gen Pract1994https://conductscience.org/library/papers/8204336PubMed
67823228Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion.J Gen Intern Med1994https://conductscience.org/library/papers/7823228PubMed
77715044The accuracy of drug information from pharmaceutical sales representatives.JAMA1995https://conductscience.org/library/papers/7715044PubMed
87641153Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.CMAJ1995https://conductscience.org/library/papers/7641153PubMed
98829983Teaching information mastery: evaluating information provided by pharmaceutical representatives.Fam Med1995https://conductscience.org/library/papers/8829983PubMed
1010159647Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.Health Mark Q1996https://conductscience.org/library/papers/10159647PubMed
118769907Physicians, pharmaceutical sales representatives, and the cost of prescribing.Arch Fam Med1996https://conductscience.org/library/papers/8769907PubMed
128911290Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.CMAJ1996https://conductscience.org/library/papers/8911290PubMed
138945688Characteristics of materials distributed by drug companies. An evaluation of appropriateness.J Gen Intern Med1996https://conductscience.org/library/papers/8945688PubMed
149154366What information do physicians receive from pharmaceutical representatives?Can Fam Physician1997https://conductscience.org/library/papers/9154366PubMed
159346461Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.J Gen Intern Med1997https://conductscience.org/library/papers/9346461PubMed
169447476The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians.J Clin Pharm Ther1997https://conductscience.org/library/papers/9447476PubMed
179595344Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?Int J Health Serv1998https://conductscience.org/library/papers/9595344PubMed
189673741Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.Aust N Z J Med1998https://conductscience.org/library/papers/9673741PubMed
199703533
Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group.
BMJ1998https://conductscience.org/library/papers/9703533PubMed
2010514174Reasons for not seeing drug representatives. They should be seen because they are a good resource.BMJ1999https://conductscience.org/library/papers/10514174PubMed

See all 49 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
42571643Money, Meals, and Marketing in Medicine: A 13-Year Follow-Up Survey of Physicians.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42571643PubMed
41115759Industry Interactions at Medical Conferences: Representatives' Credentials and the Disclosure of Data Limitations Influence Clinician Perceptions.J Am Board Fam Med2025https://conductscience.org/library/papers/41115759PubMed
40475212What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review.Cochrane Evid Synth Methods2023https://conductscience.org/library/papers/40475212PubMed
26812151Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.PLoS Med2016https://conductscience.org/library/papers/26812151PubMed
25556909Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.Br J Clin Pharmacol2015https://conductscience.org/library/papers/25556909PubMed
24800999Who has used internal company documents for biomedical and public health research and where did they find them?PLoS One2014https://conductscience.org/library/papers/24800999PubMed
23205141Doctors' opinions of information provided by Libyan pharmaceutical company representatives.Libyan J Med2012https://conductscience.org/library/papers/23205141PubMed
23104048Sorrell v. IMS Health: issues and opportunities for informaticians.J Am Med Inform Assoc2013https://conductscience.org/library/papers/23104048PubMed
23002397A survey of pharmaceutical company representative interactions with doctors in Libya.Libyan J Med2012https://conductscience.org/library/papers/23002397PubMed
22899894Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures.PLoS Med2012https://conductscience.org/library/papers/22899894PubMed
22505850The imperative to share clinical study reports: recommendations from the Tamiflu experience.PLoS Med2012https://conductscience.org/library/papers/22505850PubMed
21483716Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.PLoS Med2011https://conductscience.org/library/papers/21483716PubMed
21233426The inverse benefit law: how drug marketing undermines patient safety and public health.Am J Public Health2011https://conductscience.org/library/papers/21233426PubMed
20976098Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.PLoS Med2010https://conductscience.org/library/papers/20976098PubMed
20840443Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07.Br J Clin Pharmacol2010https://conductscience.org/library/papers/20840443PubMed
20574555A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.Dtsch Arztebl Int2010https://conductscience.org/library/papers/20574555PubMed
20388211Reporting bias in medical research - a narrative review.Trials2010https://conductscience.org/library/papers/20388211PubMed
20195173The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.Med Care2010https://conductscience.org/library/papers/20195173PubMed
20162413Unbalanced reporting of benefits and harms in abstracts on rofecoxib.Eur J Clin Pharmacol2010https://conductscience.org/library/papers/20162413PubMed
19885393Mandatory disclosure of pharmaceutical industry-funded events for health professionals.PLoS Med2009https://conductscience.org/library/papers/19885393PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17455990

GET https://conductscience.org/api/papers/v1/17455990/references?page=2